Don’t miss the latest developments in business and finance.

Lupin launches Mesalamine Extended-Release Capsules 0.375 g in US market

Image
Capital Market
Last Updated : May 19 2020 | 1:52 PM IST
Lupin announced the launch of authorized generic version of Bausch Health's Apriso (Mesalamine Extended-Release Capsules 0.375 g) in the U.S.

Mesalamine Extended-Release Capsules 0.375 g (authorized generic version) are indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older.

Mesalamine Extended-Release Capsules 0.375 g, RLD: Apriso had an annual sales of approximately USD 290 million in the U.S. (IQVIA MAT March 2020).

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: May 19 2020 | 1:41 PM IST

Next Story